Dolores Calderon
Family Medicine · Elk Grove, CANPI 1417989666
Payments from drug & device makers
Across 163 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$706
- GSK$378
- Novo Nordisk$299
- Exact Sciences$242
- AstraZeneca$158
- Amgen$146
- plus $965 from 18 others
What the payments were for
- Food & beverage$2,894100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 49 | $706 |
| GSK | 24 | $378 |
| Novo Nordisk | 16 | $299 |
| Exact Sciences | 10 | $242 |
| AstraZeneca | 9 | $158 |
| Amgen | 7 | $146 |
| Boehringer Ingelheim | 8 | $140 |
| Collegium Pharmaceutical, Inc. | 7 | $130 |
| Ironwood Pharmaceuticals, Inc | 6 | $103 |
| Ardelyx, Inc. | 4 | $101 |
| Phathom Pharmaceuticals, Inc. | 4 | $68 |
| Astellas Pharma US Inc | 3 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $58 |
| Nestle Healthcare Nutrition Inc. | 2 | $50 |
| AbbVie | 2 | $43 |
| Pfizer | 1 | $37 |
| Agios Pharmaceuticals, Inc. | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Botanix SB Inc | 1 | $17 |
| Medtronic | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
How this compares
$2,894 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 45 | $39,816 |
| MounjaroTirzepatide | 27 | $36,104 |
| OzempicSemaglutide | 17 | $21,416 |
| FarxigaDapagliflozin Propanediol | 17 | $19,944 |
| XareltoRivaroxaban | 20 | $16,255 |
| EntrestoSacubitril/Valsartan | 12 | $13,548 |
| EliquisApixaban | 18 | $11,758 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $7,973 |
| VascepaIcosapent Ethyl | 14 | $7,861 |
| Atorvastatin Calcium | 222 | $3,225 |
| Glipizide-MetforminGlipizide/Metformin Hcl | 19 | $2,725 |
| Gabapentin | 105 | $2,546 |
| Losartan Potassium | 163 | $2,435 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $2,105 |
| Duloxetine Hcl | 29 | $2,046 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $140 | $39,81645 claims |
| Lilly USA, LLCMounjaro | $706 | $36,10427 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $158 | $27,91630 claims |
| Novo NordiskOzempic | $299 | $21,41617 claims |
| PfizerEliquis | $37 | $11,75818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,533 family medicine providers in California.
Other family medicine in Elk Grove
- Dung leElk Grove$4.1M
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.